Beneficial Response to Phosphate Lowering Therapy in Normophosphatemic Tumoral Calcinosis.
作者信息
Soumya Sarayu, Prasad Nandini, Jabbar Puthiyaveettil Khadar, Hussain Sajid, Jayakumari Chellamma, Nair Abilash
机构信息
Department of Endocrinology and Metabolism, Government Medical College, Thiruvananthapuram, Kerala, India.
Pediatrics, Health Services Department, Government of Kerala, Kerala, India.
出版信息
Indian Pediatr. 2021 Jan 15;58(1):88-89. doi: 10.1007/s13312-021-2109-6.
Abstract
摘要
相似文献
1
Beneficial Response to Phosphate Lowering Therapy in Normophosphatemic Tumoral Calcinosis.正常血磷性肿瘤性钙化对降磷治疗的有益反应
Indian Pediatr. 2021 Jan 15;58(1):88-89. doi: 10.1007/s13312-021-2109-6.
2
Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms.高磷血症性家族性肿瘤性钙化症：对乙酰唑胺的反应及推测的机制。
Am J Med Genet A. 2014 Jun;164A(6):1545-9. doi: 10.1002/ajmg.a.36476. Epub 2014 Mar 25.
3
Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?成纤维细胞生长因子 23 复合杂合突变引起的高磷血症性肿瘤性钙化症：为更好地控制血磷，有哪些治疗选择？
Pediatr Nephrol. 2018 Jul;33(7):1263-1267. doi: 10.1007/s00467-018-3945-z. Epub 2018 Mar 28.
4
Hyperphosphatemic tumoural calcinosis.高磷血症性肿瘤性钙化症
BMJ Case Rep. 2016 Jan 25;2016:bcr2015213537. doi: 10.1136/bcr-2015-213537.
5
Hyperphosphataemic tumoral calcinosis.高磷血症性肿瘤性钙化症
Lancet. 2019 Jan 12;393(10167):168. doi: 10.1016/S0140-6736(18)33045-9.
6
Familial hyperphosphatemic tumoral calcinosis in an unusual and usual sites and dramatic improvement with the treatment of acetazolamide, sevelamer and topical sodium thiosulfate.家族性高磷血症性肿瘤性钙化症在不常见和常见部位的表现，以及乙酰唑胺、司维拉姆和局部硫代硫酸钠治疗的显著改善。
J Pediatr Endocrinol Metab. 2021 Apr 6;34(6):813-816. doi: 10.1515/jpem-2020-0359. Print 2021 Jun 25.
7
Topical Sodium Thiosulfate: A Treatment for Calcifications in Hyperphosphatemic Familial Tumoral Calcinosis?局部硫代硫酸钠：治疗高磷血症性家族性肿瘤性钙化症的钙化？
J Clin Endocrinol Metab. 2016 Jul;101(7):2810-5. doi: 10.1210/jc.2016-1087. Epub 2016 May 10.
8
Diffuse uremic tumoral calcinosis in a patient on long-term hemodialysis.长期血液透析患者的弥漫性尿毒症性肿瘤性钙化。
J Clin Rheumatol. 2011 Aug;17(5):272-4. doi: 10.1097/RHU.0b013e3182288acd.
9
Hyperphosphataemic familial tumoral calcinosis: case report of a rare and challenging disease.高磷血症性家族性肿瘤性钙化症：一种罕见且具有挑战性疾病的病例报告
Scand J Rheumatol. 2020 Jan;49(1):80-81. doi: 10.1080/03009742.2019.1602883. Epub 2019 Jun 19.
10
Hyperostosis with hyperphosphatemia and tumoral calcinosis: a case report.伴有高磷血症和肿瘤性钙化的骨质增生：一例报告
Pediatr Nephrol. 2007 Aug;22(8):1235-7. doi: 10.1007/s00467-007-0476-4. Epub 2007 Apr 17.
本文引用的文献
1
Differential response of idiopathic sporadic tumoral calcinosis to bisphosphonates.
Indian J Endocrinol Metab. 2014 Jul;18(4):521-5. doi: 10.4103/2230-8210.137511.
2
Calcinosis cutis: part I. Diagnostic pathway.皮肤钙化病：第一部分。诊断途径。
J Am Acad Dermatol. 2011 Jul;65(1):1-12; quiz 13-4. doi: 10.1016/j.jaad.2010.08.038.
3
Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis.SAMD9 蛋白功能特征分析，该蛋白在低磷血症性家族性肿瘤性钙质沉着症中缺失。
J Invest Dermatol. 2011 Mar;131(3):662-9. doi: 10.1038/jid.2010.387. Epub 2010 Dec 16.
4
Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations.新型 GALNT3 突变引起的家族性肿瘤性钙化症的临床变异性。
Am J Med Genet A. 2010 Apr;152A(4):896-903. doi: 10.1002/ajmg.a.33337.
5
Idiopathic sporadic tumoral calcinosis of the hip: successful oral bisphosphonate therapy.
Endocr Pract. 2007 Mar-Apr;13(2):182-6. doi: 10.4158/EP.13.2.182.
6
Proposal for a pathogenesis-based classification of tumoral calcinosis.基于发病机制的肿瘤性钙化分类方案。
Int J Dermatol. 1996 Apr;35(4):265-71. doi: 10.1111/j.1365-4362.1996.tb02999.x.
Zotero 插件